menu
    • menu

    Company profile for AZTIQ PHARMA

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AZTIQ PHARMAIceland Flag
    Country
    Country
    Iceland
    Address
    Address
    --
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aztiq.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innobic, Aztiq acquire Lotus Pharmaceutical, Adalvo for $475m
    Innobic, Aztiq acquire Lotus Pharmaceutical, Adalvo for $475m

    30 May 2022

    // NATIONTHAILAND

    https://www.nationthailand.com/business/40015906

    NATIONTHAILAND
    30 May 2022
    Share Share
    Aztiq and Innobic conclude acquisition of AEMH for $500m
    Aztiq and Innobic conclude acquisition of AEMH for $500m

    10 May 2022

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/aztiq-innobic-acquire-aemh/

    PHARMACEUTICAL-TECHNOLOGY
    10 May 2022
    Share Share
    Robert Wessman-led Aztiq completes $500M transaction in an alliance with Innobic
    Robert Wessman-led Aztiq completes $500M transaction in an alliance with Innobic

    09 May 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/robert-wessman-led-aztiq-completes-500-million-transaction-in-an-alliance-with-innobic-to-create-an-international-pharma-powerhouse-301542821.html

    PRNEWSWIRE
    09 May 2022
    Share Share
    Aztiq-Innobic consortium to buy Alvogen subsidiary for $475m
    Aztiq-Innobic consortium to buy Alvogen subsidiary for $475m

    26 Nov 2021

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/aztiq-innobic-alvogen/

    PHARMACEUTICAL-TECHNOLOGY
    26 Nov 2021
    Share Share
    Aztiq Buys 17% Stake in Alvogen US
    Aztiq Buys 17% Stake in Alvogen US

    30 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210630005694/en

    BUSINESSWIRE
    30 Jun 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search